16-68738309-C-G
Variant summary
Our verdict is Uncertain significance. Variant got -1 ACMG points: 0P and 1B. BS2_Supporting
This summary comes from the ClinGen Evidence Repository: The c.61C>G (p.Leu21Val) variant results in a non-synonymous amino acid change in exon 2. This variant is present in 5 of 188,446 alleles (0.00003) in gnomAD, present exclusively in the East Asian subpopulation with 5 of 12,882 alleles (0.00039). This variant has been observed in at least three individuals without DGC, SRC tumour or LBC and whose families do not suggest HDGC (BS2_supporting). In summary, the clinical significance of this variant is uncertain based on ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BS2_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10580066/MONDO:0007648/007
Frequency
Consequence
NM_004360.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH1 | NM_004360.5 | c.61C>G | p.Leu21Val | missense_variant | Exon 2 of 16 | ENST00000261769.10 | NP_004351.1 | |
CDH1 | NM_001317184.2 | c.61C>G | p.Leu21Val | missense_variant | Exon 2 of 15 | NP_001304113.1 | ||
CDH1 | NM_001317185.2 | c.-1555C>G | 5_prime_UTR_variant | Exon 2 of 16 | NP_001304114.1 | |||
CDH1 | NM_001317186.2 | c.-1759C>G | 5_prime_UTR_variant | Exon 2 of 15 | NP_001304115.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH1 | ENST00000261769.10 | c.61C>G | p.Leu21Val | missense_variant | Exon 2 of 16 | 1 | NM_004360.5 | ENSP00000261769.4 | ||
CDH1 | ENST00000422392.6 | c.61C>G | p.Leu21Val | missense_variant | Exon 2 of 15 | 1 | ENSP00000414946.2 | |||
CDH1 | ENST00000566612.5 | n.61C>G | non_coding_transcript_exon_variant | Exon 2 of 15 | 1 | ENSP00000454782.1 | ||||
CDH1 | ENST00000566510.5 | n.61C>G | non_coding_transcript_exon_variant | Exon 2 of 15 | 5 | ENSP00000458139.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000255 AC: 4AN: 157096Hom.: 0 AF XY: 0.0000241 AC XY: 2AN XY: 82932
GnomAD4 exome AF: 0.00000501 AC: 7AN: 1398254Hom.: 0 Cov.: 30 AF XY: 0.00000290 AC XY: 2AN XY: 689734
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
Hereditary diffuse gastric adenocarcinoma Uncertain:2
This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 21 of the CDH1 protein (p.Leu21Val). This variant is present in population databases (no rsID available, gnomAD 0.04%). This missense change has been observed in individual(s) with CDH1-related conditions (PMID: 30287823, 36436516). ClinVar contains an entry for this variant (Variation ID: 230175). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
PS4_Supporting; BS2_Supporting (PMID: 30311375) -
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
This missense variant replaces leucine with valine at codon 21 of the CDH1 protein. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals with a family history of breast or gastric cancer (PMID: 36436516). This variant has been observed in at least three individuals without diffuse gastric cancer, signet ring cell tumor or lobular breast cancer and whose families do not suggest hereditary diffuse gastric adenocarcinoma (ClinVar SCV001437603.2). This variant has been identified in 5/188446 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
CDH1-related diffuse gastric and lobular breast cancer syndrome Uncertain:1
The c.61C>G (p.Leu21Val) variant results in a non-synonymous amino acid change in exon 2. This variant is present in 5 of 188,446 alleles (0.00003) in gnomAD, present exclusively in the East Asian subpopulation with 5 of 12,882 alleles (0.00039). This variant has been observed in at least three individuals without DGC, SRC tumour or LBC and whose families do not suggest HDGC (BS2_supporting). In summary, the clinical significance of this variant is uncertain based on ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BS2_supporting. -
Familial cancer of breast Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at